Clave
Clave is a venture capital firm established in 2002 and located in Pamplona, Spain. The company focuses on investment management, targeting sectors such as technology transfer, health, food technology, growth, and energy. Clave aims to support innovative companies and projects that demonstrate potential for significant impact and growth in these industries. Through its investment strategies, Clave contributes to the development of new technologies and solutions, fostering advancement in areas crucial to societal progress and sustainability.
Corify Care
Venture Round in 2024
Corify Care SL is a medical technology company based in Madrid, Spain, focused on improving the treatment of atrial fibrillation through its innovative non-invasive electrocardiographic imaging device, ACORYS. This device allows healthcare professionals to visualize the electrical activity of the heart in real time without the need for invasive procedures, such as catheters or complex imaging techniques like MRI or CT scans. By addressing the limitations of existing solutions, ACORYS enhances the clinical management of cardiac arrhythmias, enabling accurate mapping and identification of optimal treatment strategies for patients. The technology has the potential to benefit over 10 million atrial fibrillation patients in Europe alone. Established in 2019, Corify Care is backed by leading experts in cardiac arrhythmias, positioning it as a promising player in the medical device sector.
Corify Care
Seed Round in 2021
Corify Care SL is a medical technology company based in Madrid, Spain, focused on improving the treatment of atrial fibrillation through its innovative non-invasive electrocardiographic imaging device, ACORYS. This device allows healthcare professionals to visualize the electrical activity of the heart in real time without the need for invasive procedures, such as catheters or complex imaging techniques like MRI or CT scans. By addressing the limitations of existing solutions, ACORYS enhances the clinical management of cardiac arrhythmias, enabling accurate mapping and identification of optimal treatment strategies for patients. The technology has the potential to benefit over 10 million atrial fibrillation patients in Europe alone. Established in 2019, Corify Care is backed by leading experts in cardiac arrhythmias, positioning it as a promising player in the medical device sector.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.